Healthcare provider profile · identity verified

Jerome Andrew Kessler, M.D.

Family Practice · SIDNEY, MT · NPI 1942551106

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	456	100
Gabapentin	Gabapentin	432	93
Metoprolol Succinate	Metoprolol Succinate	404	104
Furosemide	Furosemide	388	83
Famotidine	Famotidine	383	96
Atorvastatin Calcium	Atorvastatin Calcium	351	104
Levothyroxine Sodium	Levothyroxine Sodium	254	51
Potassium Chloride	Potassium Chloride	242	63
Alprazolam	Alprazolam	233	36
Montelukast Sodium	Montelukast Sodium	229	60
Oxycodone Hcl	Oxycodone Hcl	226	55
Eliquis	Apixaban	216	35
Spironolactone	Spironolactone	207	53
Allopurinol	Allopurinol	200	45
Amlodipine Besylate	Amlodipine Besylate	194	53
Prednisone	Prednisone	151	42
Tamsulosin Hcl	Tamsulosin Hcl	148	44
Lisinopril	Lisinopril	132	35
Azithromycin	Azithromycin	127	49
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	127	31
Rosuvastatin Calcium	Rosuvastatin Calcium	125	30
Lorazepam	Lorazepam	121	25
Doxycycline Hyclate	Doxycycline Hyclate	118	63
Metoprolol Tartrate	Metoprolol Tartrate	113	26
Topiramate	Topiramate	110	29
Irbesartan	Irbesartan	106	25
Sertraline Hcl	Sertraline Hcl	106	21
Pantoprazole Sodium	Pantoprazole Sodium	104	28
Fluticasone Propionate	Fluticasone Propionate	100	35
Ezetimibe	Ezetimibe	99	33
Jardiance	Empagliflozin	99	24
Venlafaxine Hcl Er	Venlafaxine Hcl	99	15
Losartan Potassium	Losartan Potassium	96	23
Tresiba Flextouch U-200	Insulin Degludec	92	20
Hydrochlorothiazide	Hydrochlorothiazide	91	19
Finasteride	Finasteride	90	23
Metoclopramide Hcl	Metoclopramide Hcl	89	24
Albuterol Sulfate Hfa	Albuterol Sulfate	87	38
Ropinirole Hcl	Ropinirole Hcl	84	suppressed
Simvastatin	Simvastatin	83	23
Trazodone Hcl	Trazodone Hcl	83	27
Pioglitazone Hcl	Pioglitazone Hcl	82	23
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	80	25
Ozempic	Semaglutide	74	suppressed
Budesonide	Budesonide	70	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	67	20
Fluconazole	Fluconazole	64	24
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	60	suppressed
Mirtazapine	Mirtazapine	56	17
Ventolin Hfa	Albuterol Sulfate	56	19
M-Natal Plus	Pnv,calcium 72/Iron/Folic Acid	55	suppressed
Metformin Hcl	Metformin Hcl	53	12
Metformin Hcl Er	Metformin Hcl	53	14
Duloxetine Hcl	Duloxetine Hcl	52	11
Digoxin	Digoxin	47	13
Esomeprazole Magnesium	Esomeprazole Magnesium	47	suppressed
Pregabalin	Pregabalin	46	suppressed
Midodrine Hcl	Midodrine Hcl	45	suppressed
Xarelto	Rivaroxaban	45	suppressed
Bupropion Xl	Bupropion Hcl	44	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	44	suppressed
Amiodarone Hcl	Amiodarone Hcl	43	11
Citalopram Hbr	Citalopram Hydrobromide	43	suppressed
Tresiba Flextouch U-100	Insulin Degludec	42	suppressed
Diltiazem Hcl	Diltiazem Hcl	39	suppressed
Paroxetine Hcl	Paroxetine Hcl	39	suppressed
Azelastine Hcl	Azelastine Hcl	38	18
Demeclocycline Hcl	Demeclocycline Hcl	37	suppressed
Fentanyl	Fentanyl	37	suppressed
Alendronate Sodium	Alendronate Sodium	36	11
Torsemide	Torsemide	36	suppressed
Carvedilol	Carvedilol	35	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	35	11
Trulicity	Dulaglutide	35	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	34	suppressed
Aripiprazole	Aripiprazole	34	suppressed
Donepezil Hcl	Donepezil Hcl	34	suppressed
Ondansetron Odt	Ondansetron	34	20
Triamcinolone Acetonide	Triamcinolone Acetonide	34	21
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Metolazone	Metolazone	32	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	31	suppressed
Tramadol Hcl	Tramadol Hcl	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	12
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	25	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Novolog Flexpen	Insulin Aspart	23	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	22	suppressed
Clonazepam	Clonazepam	22	suppressed
Dilt-Xr	Diltiazem Hcl	20	suppressed
Methimazole	Methimazole	20	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	20	suppressed
Nystatin	Nystatin	20	suppressed
Eplerenone	Eplerenone	19	suppressed
Hydroxyurea	Hydroxyurea	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	18	suppressed
Metronidazole	Metronidazole	18	11
Morphine Sulfate	Morphine Sulfate	18	11
Buspirone Hcl	Buspirone Hcl	17	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Trintellix	Vortioxetine Hydrobromide	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Ibandronate Sodium	Ibandronate Sodium	16	suppressed
Primidone	Primidone	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Temazepam	Temazepam	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Estradiol	Estradiol	14	suppressed
Humira(Cf) Pen	Adalimumab	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Humira Pen	Adalimumab	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	13	suppressed
Aliskiren	Aliskiren Hemifumarate	12	suppressed
Colchicine	Colchicine	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Lactulose	Lactulose	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Praluent Pen	Alirocumab	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Roflumilast	Roflumilast	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Selegiline Hcl	Selegiline Hcl	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error